BIGG

Difelikefalin for treating pruritus in people having haemodialysis

England. National Institute for Health and Care Excellence.

Année de publication: 2023

Evidence-based recommendations on difelikefalin (Kapruvia) for pruritus in adults with chronic kidney disease having haemodialysis.

Pruritus/drug therapy, Antipruritics/therapeutic use, Renal Dialysis/adverse effects, Quality of Life

Texte intégral

WordPress version 4.9.8
BVS-Site Plugin version 0.6.0